Severe hypogylcemia after RYGB is an increasingly recognized complication, possibly due to hyperinsulinemia and β-cell proliferation from increased GLP-1 activity, or failure of islet cell regression in diabetic patients post-RYGB [28]. This evidence concerns the gene GCG and hyperinsulinism.